RFA-TW-21-003: Fogarty Global Trauma and Injury Research Training Program (D43 Clinical Trial Optional)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2021.
National Institutes of Health offered grants to colleges and universities. Applications closed on April 16, 2021.
From the official notice on Grants.gov, last changed February 17, 2021. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeD43
- Clinical trialsOptional
- Funded byFIC
- Median yearly award$269,698
- Typical project length6 years
- D43, International Research Training Grant. Research training programs for scientists from low- and middle-income countries. Other open D43 notices.
Projects funded under RFA-TW-21-003 were run by John E. Fogarty International Center for Advanced Study in the Health Sciences (FIC, 10 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read RFA-TW-21-003 in the NIH Guide.
Key dates
| Posted | February 17, 2021 |
|---|---|
| Deadline | April 16, 2021 |
| Archived by Grants.gov | May 22, 2021 |
Who can apply
This opportunity was open to colleges and universities.
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) .
Is this a realistic fit?
- Most of the money in the 2 programs behind this notice (76% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The overall objective of this Funding Opportunity Announcement (FOA) is to strengthen trauma and injury research capacity at academic institutions in low- and middle-income countries (LMICs) through support for research training programs.
Funded under RFA-TW-21-003 so far
NIH funded 10 projects under RFA-TW-21-003 in fiscal 2021 to 2026, at 10 institutions. The median yearly award was $269,698.
Who has won Extramural Research Programs in the Neurosciences and Neurological Disorders grants before
From fiscal 2021 to 2025, Extramural Research Programs in the Neurosciences and Neurological Disorders (93.853) awarded $9.1 billion across 8,641 grant awards, an average of $1.0 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The General Hospital Corporation | Massachusetts | 203 | $288 million |
| The Regents of the University of California, San Francisco | California | 248 | $277 million |
| The Johns Hopkins University | Maryland | 230 | $276 million |
| The Trustees of Columbia University in the City of New York | New York | 188 | $226 million |
| Regents of the University of Michigan | Michigan | 179 | $221 million |
Who has won International Research and Research Training grants before
From fiscal 2021 to 2025, International Research and Research Training (93.989) awarded $329 million across 802 grant awards, an average of $409,951 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Yale Univ | Connecticut | 19 | $13.2 million |
| Makerere University College of Health Sciences | 28 | $10.2 million | |
| The Johns Hopkins University | Maryland | 20 | $9.5 million |
| University of North Carolina at Chapel Hill | North Carolina | 22 | $9.3 million |
| University of Maryland, Baltimore | Maryland | 14 | $8.7 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-TW-21-003 still open?
No. It closed on April 16, 2021.
Who can apply for Fogarty Global Trauma and Injury Research Training Program (D43 Clinical Trial Optional)?
National Institutes of Health accepted applications from colleges and universities. The notice adds further conditions, so read its eligibility section.
What is the deadline for Fogarty Global Trauma and Injury Research Training Program (D43 Clinical Trial Optional)?
Closed April 16, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under RFA-TW-21-003?
NIH RePORTER lists 10 projects funded under RFA-TW-21-003 in fiscal 2021 to 2026, at 10 institutions. The most were at Yale University, University of Iowa, University of California Los Angeles.
Who has won Extramural Research Programs in the Neurosciences and Neurological Disorders grants before?
The largest recipients over five fiscal years were The General Hospital Corporation, The Regents of the University of California, San Francisco, The Johns Hopkins University. The program made 8,641 awards worth $9.1 billion in that time.
Similar open grants
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)